FDA — authorised 30 March 1984
- Application: NDA018938
- Marketing authorisation holder: NORDIC PHARMA
- Status: supplemented
FDA authorised DDAVP on 30 March 1984
Yes. FDA authorised it on 30 March 1984; FDA authorised it on 6 September 1995.
NORDIC PHARMA holds the US marketing authorisation.